{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:23:53Z","timestamp":1788870233730,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Division of Microbiology and Infectious Diseases, NIAID","award":["HHSN272201000023I"],"award-info":[{"award-number":["HHSN272201000023I"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.antiviral.2014.07.007","type":"journal-article","created":{"date-parts":[[2014,7,19]],"date-time":"2014-07-19T15:15:16Z","timestamp":1405782916000},"page":"10-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["\u03b2-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism"],"prefix":"10.1016","volume":"110","author":[{"given":"Chandrav","family":"De","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma S.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Chavre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred K.","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung K.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F.","family":"Moffat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.antiviral.2014.07.007_b0005","first-page":"32","article-title":"Managing herpes zoster in immunocompromised patients","volume":"14","author":"Ahmed","year":"2007","journal-title":"Herpes"},{"issue":"4","key":"10.1016\/j.antiviral.2014.07.007_b0010","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF02116525","article-title":"Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus","volume":"14","author":"Andrei","year":"1995","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.007_b0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","article-title":"Varicella-zoster virus","volume":"9","author":"Arvin","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"issue":"13","key":"10.1016\/j.antiviral.2014.07.007_b0020","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1021\/jm990543n","article-title":"Structure\u2013activity relationships of (E)-5-(2-bromovinyl)uracil and related pyrimidine nucleosides as antiviral agents for herpes viruses","volume":"43","author":"Choi","year":"2000","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.antiviral.2014.07.007_b0025","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1128\/AAC.39.4.979","article-title":"Use of 2\u2032-fluoro-5-methyl-beta-l-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein\u2013Barr virus","volume":"39","author":"Chu","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.07.007_b0030","unstructured":"Cohen, J.I., Straus, S.E., Arvin, A.M., 2007. Varicella-zoster virus replication, pathogenesis, and management, fifth ed. In: Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, M.A., Roizman, B., Straus, S.E. (Eds.), Fields Virology, vol. 2. Lippincott-Williams and Wilkins, Philadelphia, pp. 2773\u20132818."},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.007_b0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.antiviral.2014.07.007_b0040","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.mib.2005.08.010","article-title":"Recent highlights in the development of new antiviral drugs","volume":"8","author":"De Clercq","year":"2005","journal-title":"Curr. Opin. Microbiol."},{"issue":"6","key":"10.1016\/j.antiviral.2014.07.007_b0045","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1073\/pnas.76.6.2947","article-title":"(E)-5-(2-bromovinyl)-2\u2032-deoxyuridine: a potent and selective anti-herpes agent","volume":"76","author":"De Clercq","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.007_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2125.1998.00050.x","article-title":"Sorivudine and 5-fluorouracil; a clinically significant drug\u2013drug interaction due to inhibition of dihydropyrimidine dehydrogenase","volume":"46","author":"Diasio","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.antiviral.2014.07.007_b0055","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1023\/A:1011919319810","article-title":"5\u2032-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter","volume":"15","author":"Han","year":"1998","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.antiviral.2014.07.007_b0060","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1023\/A:1011945420235","article-title":"Cellular uptake mechanism of amino acid ester prodrugs in Caco-2\/hPEPT1 cells overexpressing a human peptide transporter","volume":"15","author":"Han","year":"1998","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.007_b0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0166-0934(98)00176-1","article-title":"Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus","volume":"79","author":"Hawrami","year":"1999","journal-title":"J. Virol. Methods"},{"issue":"9","key":"10.1016\/j.antiviral.2014.07.007_b0070","first-page":"863","article-title":"A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia","volume":"5","author":"Holcomb","year":"2006","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.antiviral.2014.07.007_b0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/095632029600700307","article-title":"Physicochemical properties, bioconversion and disposition of lipophilic prodrugs of 2\u2032,3postherpetic-dideoxycytidine","volume":"7","author":"Ibrahim","year":"1996","journal-title":"Antiviral Chem. Chemother."},{"issue":"10","key":"10.1016\/j.antiviral.2014.07.007_b0080","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1128\/AAC.00571-11","article-title":"Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase","volume":"55","author":"James","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.007_b0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/AAC.29.1.171","article-title":"Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase","volume":"29","author":"Karlstr\u00f6m","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"issue":"18","key":"10.1016\/j.antiviral.2014.07.007_b0090","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2165\/00003495-200464180-00011","article-title":"Brivudin (bromovinyl deoxyuridine)","volume":"64","author":"Keam","year":"2004","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.antiviral.2014.07.007_b0095","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF01221032","article-title":"Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2\u2032-deoxyuridine","volume":"120","author":"Keizer","year":"1994","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.antiviral.2014.07.007_b0100","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1084\/jem.20040634","article-title":"Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha","volume":"200","author":"Ku","year":"2004","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.antiviral.2014.07.007_b0105","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1124\/mol.58.5.1109","article-title":"Metabolism and mode of inhibition of varicella-zoster virus by l-beta-5-bromovinyl-(2-hydroxymethyl)-(1,3-dioxolanyl)uracil is dependent on viral thymidine kinase","volume":"58","author":"Li","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.antiviral.2014.07.007_b0110","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jac\/dkh244","article-title":"Pharmacokinetics of valacyclovir","volume":"53","author":"MacDougall","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.antiviral.2014.07.007_b0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0166-3542(92)90026-2","article-title":"Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT","volume":"17","author":"McGuigan","year":"1992","journal-title":"J. Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.07.007_b0120","series-title":"Handbook of Animal Models of Infection","first-page":"973","article-title":"Varicella-zoster virus infection of T cells and skin in the SCID-Hu mouse model","author":"Moffat","year":"1999"},{"issue":"9","key":"10.1016\/j.antiviral.2014.07.007_b0125","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1128\/JVI.69.9.5236-5242.1995","article-title":"Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-Hu mice","volume":"69","author":"Moffat","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.07.007_b0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2014.07.007_b0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jviromet.2008.07.033","article-title":"Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts","volume":"154","author":"Oliver","year":"2008","journal-title":"J. Virol. Methods"},{"issue":"22","key":"10.1016\/j.antiviral.2014.07.007_b0140","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.07.007_b0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","article-title":"A three-dimensional model to analyze drug\u2013drug interactions","volume":"14","author":"Prichard","year":"1990","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.007_b0150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bmcl.2012.11.027","article-title":"2\u2032-Fluoro-6\u2032-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: in vitro anti-HBV activity against the lamivudine-entecavir resistant triple mutant and its mechanism of action","volume":"23","author":"Rawal","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.007_b0155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.antiviral.2010.03.007","article-title":"Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice","volume":"86","author":"Rowe","year":"2010","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.007_b0160","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4065\/84.3.274","article-title":"Herpes zoster (shingles) and postherpetic neuralgia","volume":"84","author":"Sampathkumar","year":"2009","journal-title":"Mayo Clin. Proc."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2014.07.007_b0165","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/522145","article-title":"Varicella vaccine effectiveness in the US vaccination program: a review","volume":"197","author":"Seward","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.antiviral.2014.07.007_b0170","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/jmv.1890380406","article-title":"Replication of varicella zoster virus in primary human keratinocytes","volume":"38","author":"Sexton","year":"1992","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.007_b0175","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/147.3.576","article-title":"Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus","volume":"147","author":"Shigeta","year":"1983","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.007_b0180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0924-8579(94)90011-6","article-title":"Chemotherapy of varicella zoster virus infections","volume":"4","author":"Snoeck","year":"1994","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"22","key":"10.1016\/j.antiviral.2014.07.007_b0185","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1021\/jm00100a029","article-title":"l-Thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth","volume":"35","author":"Spadari","year":"1992","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.007_b0190","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3565(24)29450-7","article-title":"Drug synergism: its detection and applications","volume":"298","author":"Tallarida","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"17","key":"10.1016\/j.antiviral.2014.07.007_b0195","doi-asserted-by":"crossref","first-page":"11501","DOI":"10.1128\/JVI.79.17.11501-11506.2005","article-title":"Replication of varicella-zoster virus in human skin organ culture","volume":"79","author":"Taylor","year":"2005","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.antiviral.2014.07.007_b0200","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/JVI.78.6.2853-2862.2004","article-title":"Roscovitine, a cyclin dependent kinase inhibitor, prevents replication of varicella-zoster virus","volume":"78","author":"Taylor","year":"2004","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2014.07.007_b0205","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"Vazquez","year":"2004","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.antiviral.2014.07.007_b0210","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1128\/JVI.02666-06","article-title":"Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system","volume":"81","author":"Zhang","year":"2007","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421400206X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421400206X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T17:48:52Z","timestamp":1746294532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421400206X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":42,"alternative-id":["S016635421400206X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.07.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}